Drugs: Prices

Department of Health and Social Care written question – answered at on 30 March 2023.

Alert me about debates like this

Photo of Chris Green Chris Green Conservative, Bolton West

To ask the Secretary of State for Health and Social Care, pursuant to the answer of 30 January 2023 to Question 129959 on Drugs: Prices, how many of the 24 commercial agreements that resulted in non-uniform pricing since 2020 were agreed through (a) The Cancer Drugs Fund, (b) routine commissioning and (c) the Innovative Medicines Fund.

Photo of Will Quince Will Quince Minister of State (Department of Health and Social Care)

Of the 24 commercial agreements that resulted in non-uniform pricing since 2020, 11 were agreed through the Cancer Drugs Fund and 13 were agreed through routine commissioning. NHS England and NHS Improvement (NHSE&I) and the National Institute for Health and Care Excellence (NICE) will lead a public engagement exercise on proposals for the Innovative Medicine Fund in due course. NHSE&I and NICE will continue to work collaboratively in line with NHSE&I’s published commercial framework to negotiate deals with industry that enable patients to access the most innovative and effective new medicines and ensure the National Health Service gets the best value.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.